Orphan Drugs Korean Pharmas’ Ticket To Global Success?
This article was originally published in PharmAsia News
Amid limited resources and marketing capabilities, South Korean pharmas are increasingly opting for improved and orphan drugs as their ticket to major global markets. Several companies shared their varying strategies for international success during a recent symposium in Seoul.
Register for our free email digests: